The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of nab-paclitaxel in refractory CIMP-high metastatic colorectal cancer.
 
Michael J. Overman
Research Funding - Celgene
 
Bryan K. Kee
No Relationships to Disclose
 
David R. Fogelman
Stock and Other Ownership Interests - GTx
Consulting or Advisory Role - Incyte
 
Cathy Eng
Honoraria - Lilly; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech; Sanofi
Research Funding - ArQule; Keryx
Travel, Accommodations, Expenses - Genentech/Roche
 
Eduardo Vilar Sanchez
No Relationships to Disclose
 
Rachna T. Shroff
Consulting or Advisory Role - Celgene
Research Funding - Celgene
 
Arvind Dasari
No Relationships to Disclose
 
Robert A. Wolff
Honoraria - Precision Medicine Research Associates, LLC
Consulting or Advisory Role - Clovis Oncology; Precision Medicine Research Associates, LLC
Travel, Accommodations, Expenses - London Health Sciences Centre (LHSC)
 
Jeffrey Morris
No Relationships to Disclose
 
Scott Kopetz
Consulting or Advisory Role - Agendia; Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Merrimack; Roche; Sanofi; Sysmex; Taiho Pharmaceutical
Research Funding - Agendia; Amgen; Biocartis; GlaxoSmithKline; Guardant Health; Roche; Sanofi; Sysmex